What is the current Camurus market capitalization?
The current market capitalization of Camurus is 38.9 B SEK.
Camurus Market capitalization 2024
Camurus Market capitalization
38.9 B SEK
Ticker
CAMX.ST
ISIN
SE0007692850
WKN
A2ABG7
In 2024, Camurus's market cap stood at 38.9 B SEK, a 130.54% increase from the 16.87 B SEK market cap in the previous year.
The Camurus Market capitalization history
| YEAR | REVENUE (undefined SEK) | GROSS MARGIN (%) | NET INCOME (undefined SEK) |
|---|---|---|---|
| 2029e | 9.44 | 16,90 | - |
| 2028e | 7.32 | 21,79 | 2.78 |
| 2027e | 5.03 | 31,71 | 1.91 |
| 2026e | 4.32 | 36,88 | 1.89 |
| 2025e | 3.07 | 51,94 | 1.04 |
| 2024e | 1.93 | 82,57 | 0.34 |
| 2023 | 1.72 | 92,87 | 0.43 |
| 2022 | 0.96 | 89,20 | 0.06 |
| 2021 | 0.6 | 85,79 | -0.09 |
| 2020 | 0.34 | 89,50 | -0.17 |
| 2019 | 0.11 | 77,95 | -0.29 |
| 2018 | 0.05 | 86,17 | -0.23 |
| 2017 | 0.05 | 97,50 | -0.19 |
| 2016 | 0.11 | 98,12 | -0.08 |
| 2015 | 0.15 | 99,85 | -0.16 |
| 2014 | 0.21 | 99,68 | 0.05 |
Camurus Aktienanalyse
What does Camurus do?
Camurus AB is a Swedish biopharmaceutical company that specializes in the development of innovative medications for the treatment of serious diseases. The company was founded in 1991 by an interdisciplinary team of chemists, biologists, and drug developers and is headquartered in Lund, Sweden. Camurus AB specializes in the development of medications based on long-acting drug release technology. This technology allows medications to be administered in a very precise manner and over a longer period of time. This enables the benefits of a constant drug concentration in the blood to be utilized without requiring multiple doses per day. The core business of Camurus AB includes the development of medications for the treatment of pain, cancer, and addiction. The company works closely with clients, partners, and academic institutions to bring innovative medications to market that can have a significant impact on patients' lives. One of Camurus AB's key areas is pain therapy. The company has developed a novel technology that allows pain medications to be administered in the form of sprays and patches. This technology is based on the release of buprenorphine, a potent painkiller that previously could only be administered as repeated single doses or in the form of an implant due to its short half-life. The extended release allows for a sustained high concentration of the drug in the blood, without the need for the patient to take multiple single doses. Camurus AB is also active in oncology and has developed medications for the treatment of breast and prostate cancer that also utilize long-acting drug release. These medications help patients better tolerate the side effects of chemotherapy and improve their quality of life. Another important area for Camurus AB is addiction therapy. The company has developed a medication based on buprenorphine for the treatment of opioid dependence. This medication activates the body's own opioid receptors and reduces the cravings for further drugs. In recent years, Camurus AB has introduced several important products to the market and holds a wide portfolio of patents and protective rights. The company is committed to improving patient care and making global healthcare a better and more effective system. In conclusion, Camurus AB is an innovative biopharmaceutical company specializing in the development of medications for the treatment of pain, cancer, and addiction. The company is dedicated to improving global healthcare and works closely with clients, partners, and academic institutions to develop innovative, effective, and patient-oriented solutions. Camurus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Camurus's Market Capitalization
Camurus's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Camurus's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Camurus's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Camurus’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Camurus stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Camurus.
How has the market capitalization of Camurus developed in recent years?
The market capitalization of Camurus has increased/decreased by 130.54% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Camurus?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Camurus?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Camurus have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Camurus pay?
Over the past 12 months, Camurus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Camurus is expected to pay a dividend of 0 SEK.
What is the dividend yield of Camurus?
The current dividend yield of Camurus is .
When does Camurus pay dividends?
Camurus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Camurus?
Camurus paid dividends every year for the past 0 years.
What is the dividend of Camurus?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Camurus located?
Camurus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Camurus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Camurus from 7/17/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 7/17/2024.
When did Camurus pay the last dividend?
The last dividend was paid out on 7/17/2024.
What was the dividend of Camurus in the year 2023?
In the year 2023, Camurus distributed 0 SEK as dividends.
In which currency does Camurus pay out the dividend?
The dividends of Camurus are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Camurus
Our stock analysis for Camurus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Camurus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
